Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial

被引:308
作者
Forrest, AP
Stewart, HJ
Everington, D
Prescott, RJ
McArdle, CS
Harnett, AN
Smith, DC
George, WD
机构
[1] UNIV EDINBURGH,WESTERN GEN HOSP,MED STAT UNIT,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND
[2] UNIV EDINBURGH,WESTERN GEN HOSP,DEPT SURG,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND
[3] BEATSON ONCOL CTR,DEPT RADIOTHERAPY,GLASGOW,LANARK,SCOTLAND
[4] VICTORIA INFIRM,DEPT SURG,GLASGOW G42 9TY,LANARK,SCOTLAND
[5] UNIV GLASGOW,WESTERN INFIRM,DEPT SURG,GLASGOW,LANARK,SCOTLAND
关键词
D O I
10.1016/S0140-6736(96)02133-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background To determine whether, when primary breast cancer is treated by local excision supported by systemic therapy appropriate to the oestrogen receptor status (ER) of the tumour, local radiotherapy can be avoided. Methods We carried out a randomised controlled trial in 585 patients aged less than 70 years with primary breast cancers of 4 cm or less in size in four specialist units and seven other hospitals in Scotland. After local excision of the tumour (1 cm margin) and an axillary lymph-node clearance or sample, all patients received systemic therapy with oral tamoxifen 20 mg daily or six 3-weekly intravenous bolus injections of cyclophosphamide 600 mg, methotrexate 50 mg, and fluorouracil 600 mg per m(2), depending upon the ER concentration in the primary tumour. Patients were then randomly allocated to postoperative radical radiotherapy (50 Gy to breast with boost to the tumour bed) or to no further local treatment, The median follow-up of living patients was 5.7 years. The primary analysis was by intention to treat but since some patients did not receive systemic therapy appropriate to their ER status, a subsidiary analysis was restricted to 464 patients in whom all details of the protocol had been observed. Findings In the primary analysis survival was equal in the radiotherapy and non-radiotherapy groups (hazard ratio [HR] 0.98, 95% CI 0.67-1.44). Event-free survival showed an advantage in the irradiated patients (HR 0.54, 95% CI 0.39-0.74), largely due to fewer loco-regional relapses (HR 0.20, 95% CI 0.12-0.33). The relapse rate in the ipsilateral breast was 24.5% in the non-irradiated group and 5.8% following breast irradiation. The subsidiary analysis confirmed these findings and indicated the advantage of radiotherapy irrespective of ER concentration. There was a non-significant trend towards fewer distant metastases in the irradiated group. Interpretation After local excision of a primary breast cancer, we conclude that radiotherapy to the residual breast tissue is advisable even when selective adjuvant systemic therapy is given.
引用
收藏
页码:708 / 713
页数:6
相关论文
共 22 条
[1]  
[Anonymous], 1992, Lancet
[2]   RANDOMIZED CLINICAL-TRIAL TO ASSESS THE EFFECTIVENESS OF BREAST IRRADIATION FOLLOWING LUMPECTOMY AND AXILLARY DISSECTION FOR NODE-NEGATIVE BREAST-CANCER [J].
CLARK, RM ;
MCCULLOCH, PB ;
LEVINE, MN ;
LIPA, M ;
WILKINSON, RH ;
MAHONEY, LJ ;
BASRUR, VR ;
NAIR, BD ;
MCDERMOT, RS ;
WONG, CS ;
CORBETT, PJ .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (09) :683-689
[3]   SIGNIFICANCE OF IPSILATERAL BREAST-TUMOR RECURRENCE AFTER LUMPECTOMY [J].
FISHER, B ;
ANDERSON, S ;
FISHER, ER ;
REDMOND, C ;
WICKERHAM, DL ;
WOLMARK, N ;
MAMOUNAS, EP ;
DEUTSCH, M ;
MARGOLESE, R .
LANCET, 1991, 338 (8763) :327-331
[4]   5-YEAR RESULTS OF A RANDOMIZED CLINICAL-TRIAL COMPARING TOTAL MASTECTOMY AND SEGMENTAL MASTECTOMY WITH OR WITHOUT RADIATION IN THE TREATMENT OF BREAST-CANCER [J].
FISHER, B ;
BAUER, M ;
MARGOLESE, R ;
POISSON, R ;
PILCH, Y ;
REDMOND, C ;
FISHER, E ;
WOLMARK, N ;
DEUTSCH, M ;
MONTAGUE, E ;
SAFFER, E ;
WICKERHAM, L ;
LERNER, H ;
GLASS, A ;
SHIBATA, H ;
DECKERS, P ;
KETCHAM, A ;
OISHI, R ;
RUSSELL, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (11) :665-673
[5]  
Hawkins R A, 1981, Breast Cancer Res Treat, V1, P245, DOI 10.1007/BF01806264
[6]  
HAYWARD JL, 1983, CONSERVATIVE MANAGEM, P77
[7]  
Leake R, 1987, STEROID HORMONES PRA, P67
[8]   SECTOR RESECTION WITH OR WITHOUT POSTOPERATIVE RADIOTHERAPY FOR STAGE-I BREAST-CANCER - 5-YEAR RESULTS OF A RANDOMIZED TRIAL [J].
LILJEGREN, G ;
HOLMBERG, L ;
ADAMI, HO ;
WESTMAN, G ;
GRAFFMAN, S ;
BERGH, J ;
HUITFELDT, B .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (09) :717-722
[9]   BREAST-CONSERVING SURGERY AND TUMOR BED POSITIVITY IN PATIENTS WITH BREAST-CANCER [J].
MACMILLAN, RD ;
PURUSHOTHAM, AD ;
MALLON, E ;
RAMSAY, G ;
GEORGE, WD .
BRITISH JOURNAL OF SURGERY, 1994, 81 (01) :56-58
[10]   COMPUTING AN EXACT CONFIDENCE-INTERVAL FOR THE COMMON ODDS RATIO IN SEVERAL 2X2 CONTINGENCY-TABLES [J].
MEHTA, CR ;
PATEL, NR ;
GRAY, R .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1985, 80 (392) :969-973